Read + Share
Leonetti A, Cervati V, Minari R, Scarlattei M, et al. Liquid Biopsy and 18F-FDG PET/CT Derived Parameters as Predictive Factors of
Osimertinib Treatment in Advanced EGFR-Mutated NSCLC. Clin Lung Cancer 2024;25:e436-e445.
PMID: 39198088
|
 |
|
Leonetti A, Cervati V, Minari R, Scarlattei M, et al. Liquid Biopsy and 18F-FDG PET/CT Derived Parameters as Predictive Factors of
Osimertinib Treatment in Advanced EGFR-Mutated NSCLC. Clin Lung Cancer 2024;25:e436-e445.
PMID: 39198088
|
|
|
|